Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap4.32B
Enterprise Value4.09B
P/E Ratio94.48
PEG Ratio4.09
Price/Sales Ratio3.93
Price/Book Ratio1.63
Enterprise/Revenue3.63
Enterprise/EBITDA26.48

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.04
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue783.17M
Revenue/Share2.94
Gross Profit132.48M
EBITDA127.66M
Net Income22.49M
Diluted EPS0.08

Balance Sheet

Total Cash875.98M
Total Cash/Share3.03
Total Debt745,182
Total Debt/Equity0
Current Ratio5.95
Book Value Per Share6.9

Price History

52-Week Change-61.81
52-Week High32.14
52-Week Low10.61
Moving Average 50 Days12.61
Moving Average 200 Days15.05

Statistics

Average Volume7.87M
Shares Outstanding294.68M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.88
Payout Ratio0.01
Last Split Factor3:2
Last Split DateMay 15, 2018
AD